Get to know our clinical trials

Ensayo de trastuzumab deruxtecán en el tratamiento de tumores sólidos irresecables y/o metastásicos con mutaciones activadoras de HER2 con independencia de la histología tumoral.

In recruitment

Technical Summary

* The trials only admit a limited number of patients and are subject to inclusion and exclusion criteria. The specialist who assesses your case will inform you of the conditions required to participate in the clinical trial.

Do you want to participate in this trial?

Request an appointment for our specialists to assess whether you qualify for this clinical trial

Do you prefer to send us your reports?

If you prefer, you can send us your medical information and our specialists will evaluate your case without the need to come to the Clinica.